See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2013

Microvascular Obstruction, Infarct Size, and LV Remodeling

Presenter: Andreas M. Zeiher

January 23, 2013

Presentation Cell Therapy 2013

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Presenter: Wolfgang-Michael Franz

January 22, 2013

Presentation Cell Therapy 2013

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

Presenter: Emerson C.Perin

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation Cell Therapy 2013

IMPACT Clinical Trial Program: Findings and Strategic Update

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Presenter: Jay H. Traverse

January 22, 2013

Presentation Cell Therapy 2013

Adipose derived cells or chronic myocardial ischemia

Presenter: Francisco Fdez-Avil?s

January 22, 2013

Presentation Cell Therapy 2013

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

Presenter: Stephen G. Ellis

January 22, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Presenter: Emerson C. Perin

January 22, 2013

Advertisement

Slides

Microvascular Obstruction, Infarct Size, and LV Remodeling

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

A Randomized Double Blinded Study to Evaluate The Effect of Bone Marrow- Derived Mononuclear Stem Cells on Tissue Perfusion in Patients with Intermittent Claudication

CD-34+ Cells for Ischemic Heart Failure

IMPACT Clinical Trial Program: Findings and Strategic Update

TIME: CCTRN Study of Bone Marrow-Derived Stem Cells Following STEMI

Adipose derived cells or chronic myocardial ischemia

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Adipose-Derived Regenerative Cells in Chronic Ischemic Heart Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content